-
1دورية أكاديمية
المؤلفون: Anne M May, Maike G Sweegers, Wim H Van Harten, Martijn M Stuiver, Alina Vrieling, Richard P Meijer, Antoine G van der Heijden, Wim G Groen, Emine Akdemir, Helene Rundqvist, Annemarie M Leliveld-Kors, Vera C Rutten, Evert L Koldewijn, Siebe D Bos, Carl J Wijburg, Tom A T Marcelissen, Bart C Bongers, Valesca P Retèl
المصدر: BMJ Open, Vol 13, Iss 3 (2023)
مصطلحات موضوعية: Medicine
وصف الملف: electronic resource
-
2
المؤلفون: Virginia J. Aijtink, Vera C. Rutten, Beatrice E.M. Meijer, Renate de Jong, John L. Isaac, Wojciech G. Polak, M. Thamara P.R. Perera, Dimitri Sneiders, Hermien Hartog
المساهمون: Surgery, Anesthesiology
المصدر: Annals of Surgery, 276(2), 239-245. Lippincott Williams & Wilkins
مصطلحات موضوعية: Carcinoma, Hepatocellular, Operative Blood Salvage, Liver Neoplasms, Humans, Surgery, Neoplasm Recurrence, Local, Liver Transplantation, Retrospective Studies
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d07efe851f9cef1178eb03ca2e0a608
https://doi.org/10.1097/SLA.0000000000005476 -
3دورية أكاديمية
المصدر: International Journal of Molecular Sciences, Vol 22, Iss 6, p 2800 (2021)
مصطلحات موضوعية: bladder cancer, BCG-unresponsive, neoadjuvant chemotherapy, immune checkpoint inhibition, PD-1, PD-L1, Biology (General), QH301-705.5, Chemistry, QD1-999
وصف الملف: electronic resource
-
4
المصدر: International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 2800, p 2800 (2021)مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Review, Disease, B7-H1 Antigen, lcsh:Chemistry, 0302 clinical medicine, Risk Factors, Outcome Assessment, Health Care, PD-1, lcsh:QH301-705.5, Immune Checkpoint Inhibitors, Spectroscopy, biology, Drug Synergism, General Medicine, Computer Science Applications, 030220 oncology & carcinogenesis, Toxicity, bladder cancer, immune checkpoint inhibition, BCG-unresponsive, neoadjuvant chemotherapy, medicine.drug, PD-L1, medicine.medical_specialty, Urinary Bladder, Antibodies, Monoclonal, Humanized, Catalysis, Inorganic Chemistry, 03 medical and health sciences, SDG 3 - Good Health and Well-being, Internal medicine, medicine, Humans, Physical and Theoretical Chemistry, Adverse effect, Molecular Biology, Cisplatin, Chemotherapy, Bladder cancer, business.industry, Organic Chemistry, medicine.disease, Blockade, 030104 developmental biology, lcsh:Biology (General), lcsh:QD1-999, Urinary Bladder Neoplasms, biology.protein, business